We have developed microfluidic chips for automating molecular biology processes such as gene ligation and gene transformation from nanolitre sample volumes with parallel architecture. Unlike conventional tube methods with cumbersome pipetting procedures, all processes, including metering of samples, ligation and transformation, were carried out in the microfluidic chips through pneumatic control of the nanofluid. The microfluidic devices presented here offer an illustration of some of the basic physics that arises when trying to miniaturize and automate biological techniques.
Introduction
Microfluidics is a multidisciplinary field comprising physics, chemistry, engineering, and biotechnology; it refers to the study and manipulation of tiny volumes, nanolitres or picolitres, of liquid [1] . A major application of microfluidics is biological automation, as this involves scaling fluid manipulations from millilitres and microlitres to the nanolitre scale. This scaling is often accompanied by interesting changes in the basic fluid physics [2] , and these physical effects often introduce complications. For example, it is well known that due to the low Reynolds number of microfluidic devices, mixing is a challenge. Another example is effects derived from the large surface-area-to-volume ratio in such devices. Here we use a fundamental process in molecular biology (creation of recombinant DNA) as an example to examine how various physical effects must be taken into consideration when creating microfluidic devices for biological automation.
Construction of recombinant DNA and the transformation of the genetic material into specific target cells are indispensable techniques for molecular biology. Since the first trial of gene transformation with bacterial cells in 1970 by Mendel and Higa [3] , many variations of this basic technique have been developed for biology, medicine and biotechnology applications [4, 5] . The basic idea of transformation is the insertion of target DNA by heat shock into competent bacterial cells made competent by calcium chloride treatment. Another method instead of heat shock is electroporation (or electrotransformation) [6, 7] that applies a high electrical current for a very short time around the mixture of the target cell and target gene. This electrical shock allows insertion of charged molecules such as dyes and nucleic acids into the cells. There are other methods like microinjection, which is mainly restricted to relatively large mammalian cells instead of bacterial cells.
There have been several recent reports about the insertion of specific genes using microfabricated fluidic systems with the combination of electrical voltage control or microelectrodes based on hard materials such as silicon or glass [8] [9] [10] . The main control method of the fluid or the sample is electrical control, which is usually appropriate for the handling of several microlitres of samples. These electroporation-based gene transfer methods may not be suitable for nanolitre volumes of samples although they do allow samples and reagents to be reduced down to several microlitres compared to the conventional bench-top tube methods. Here, we report a microfluidic platform for ligation and transformation with nanolitre sample volumes. The platform uses micromechanical valves fabricated by multilayer soft lithography [11, 12] , which has been applied to the construction of microfluidic systems for the biotechnology applications such as cell sorting [13] , microchip polymerase chain reaction (PCR) [14] , and nucleic acid purification [15] as well as biophysical studies of protein crystallization [16] . In this paper, we will describe the ligation of a specific gene into a plasmid and transformation of target genes into competent cells on microfluidic systems. We will also discuss how both the fluid physics and the mechanical properties of the valves affect this process.
Materials and methods

Microfabrication
Chips were fabricated by multilayer soft lithography [11, 17] . Mask designs were created with the CAD program FluidArchitect (Fluidigm, South San Francisco, CA) and transferred to highresolution transparency masks (3389 dpi). The dimensions of the fluidic channels are 100 µm in width and 10 µm in depth, while the valve actuation channels are typically 200 µm in width and 15 µm in depth.
The ligation chip, as shown in figure 1 , within 20 mm×20 mm space, had 12 fluidic access vias, 30 valves and 9 actuation vias that allow microfluidic flow and control. The transformation chip, as shown in figure 2, within 20 mm × 20 mm space, had 8 fluidic access vias, 47 valves and 11 actuation vias that allow microfluidic flow and control. Mask moulds for the fluidic channels were made by spin-coating positive photoresist (Shipley SJR 5740) on a silicon wafer with 2000 rpm for 1 min, followed by mask exposure and development. These mould channels were rounded at 135
• C for 15 min to create a geometry that allows full valve closure. Another mould for the actuation layer was made by spinning photoresist on a separate wafer at 1600 rpm for 1 min with a resulting height of 12 µm, followed by mask exposure and development. The devices were fabricated by bonding together two layers of two-part cure silicone (GE Silicone RTV615) cast from the photoresist moulds. The bottom layer of the device, containing the flow channels, was spin coated with 20:1 parts A:B RTV615 at 2400 rpm for 1 min, and the resulting silicone layer was an 11 µm thick film. The top layer of the device, containing the actuation channels, was cast as a thick layer (5 mm thick) with 5:1 parts A:B RTV615 using a separate mould. The two layers were initially cured for 45 min at 80
• C. Actuation channel interconnect holes were then punched through the thick layer with a 20 gauge luer stub, after which it was sealed, channel side down, on the thin layer, after aligning the respective channel networks with an optical microscope. Bonding between the assembled layers was accomplished by curing the assembled devices at 80
• C for more than 90 min, followed by punching the fluidic channel interconnects. The resulting devices were cut to size and mounted on RCA cleaned cover slips (No. 1, 24 mm × 50 mm), followed by incubation at 80
• C overnight to promote adhesion. Another chip designed for both ligation and transformation having 16 fluidic access vias, 91 valves and 23 actuation vias that allow microfluidic flow and control was also fabricated (figure not shown). The volume of the three sets of mixing rings was 6, 30 and 60 nl, respectively. In order to make large volume mixers without increasing the size of the rings, we increased the depth of the mixer channels to 50 µm, while the depth of the channels in the pumping area remained at 10 µm.
For the construction of the mould structures with two different channel depths, we first spin-coated negative photoresist SU-8 50 on a silicon wafer at 2300 rpm for 45 s, followed by mask exposure and development to make the 50 µm channels. After hard baking for 1 h at 150
• C, we spin-coated positive photoresist (Shipley SJR 5740) at 2200 rpm for 1 min, followed by careful mask alignment, exposure and development. This provided the second 10 µm of 5740 layer. These mould channels were rounded at 135
• C for 15 min. Another mould for the actuation layer was made by spinning negative photoresist SU-8 2025 on a separate wafer at 3000 rpm for 45 s with a resulting height 23 µm, followed by mask exposure and development. The devices were fabricated by bonding together two layers of two-part cure silicone (GE Silicone RTV615) cast from the photoresist moulds. The silicone process was the same, except that 1800 rpm for 1 min was used for the control layer.
System setup and pneumatic control of the microfluidic chip
The chip was mounted on an inverted microscope (Nikon Eclipse TE2000-S). Fluorescence excitation was provided by a mercury lamp (100 W). A FITC filter set (Ex465-495, DM 505, BA 515-555) was used and the image was recorded by using a PC controlled colour digital camera (Sony DFW-V500).
Each actuation line on the chip was connected with a stainless steel pin (New England Small Tube, Litchfield, NH) and polyethylene tubing to an external solenoid valve controlled by a digital data I/O card (CCA, PPC1-DIO32HS; National Instruments, Austin, TX). Regulated external pressure was provided to the normally closed port, allowing the control channel to be pressurized or vented to atmosphere by switching the miniature valve. The fluidic vias for the introduction and collection of sample and buffer were connected to an external pressure source through polypropylene tips (Multiplex tips, Sorenson BioScience, Inc., West Salt Lake City, Utah). A typical pressure for driving liquid inside the chip was 0.5 to 2.0 psi (1 psi = 6.89 kPa). All the valve actuation lines were filled with fluid and each control line was connected to the pressure source. The working pressure for the actuation channels was below 5 psi. All the valves were closed before loading the reagents.
Ligation procedure on chip
The target DNA was first loaded on the chip through the 'DNA' port by opening valves 4 and 7. Once the DNA solution flowed through the whole channel, valve 7 was closed. The chamber was dead-end-filled by pushing the air into the gas-permeable chip, then valve 4 was closed. By the same method, the vectors were loaded through the 'vector' port by operating valves 5 and 7, and the enzyme were loaded through the 'enzyme' port by operating valves 6 and 7. After the chambers were filled with reagents, valves 1 and 3 were opened, and nuclease free water was loaded through the 'water' port to push the reagents into the mixing rings. Then the three solutions were mixed by opening and closing the pumping valves 9, 10, and 11 sequentially. The chip was incubated at 37
• C for 15 min on a thermal plate and then kept at room temperature to allow the ligation of the target DNA and the vector to be carried on. Finally, valves 1, 3, and 8 were opened, and the ligation products at the 'output' ports collected by applying 5 µl of distilled water for each output port. Then the recovered ligation products were mixed with 20 µl of competent cells and 80 µl of SOC medium was added to each recovered ligation product. All the samples, 105 µl of each, were loaded on antibiotic containing agar plates.
Material for ligation
Linearized plasmid vector pNEB205A containing ampicillin resistant gene and USER™ enzyme (uracil-specific excision reagent) (New England BioLabs) were used for the ligation procedure. NovaBlue Singles™ competent cells (Novagen) were used for the confirmation of the ligation procedure with the conventional off chip method. For the preparation of target DNA, GFP coding gene was amplified with conventional PCR. Thermal cycling conditions were as follows. Initial denaturing, 94
• C (2 min), 25 cycles of DNA denaturing, 94
• C (30 s); primer annealing, 61
• C (45 s); dNTP polymerizing, 72
• C (2 min); final extension, 72
• C (7 min). The primer set for 882 bp target DNA containing GFP gene containing region was 5 -GGAGACAUATGACCATGATTACGCCAAG-3 for forward and 5 -GGGAAAGUCGCTCAGTTGGAATTCTACG-3 for reverse. The PCR cocktail was 0.5 µl (0.5 ng µl 
Preparation of the selection medium
A selective medium was prepared for the blue and white screening method of transformed cells on a Luria Bertani (LB) agar plate with ampicillin, IPTG and X-gal. Tryptone (10 g), yeast extract (5 g), NaCl (10 g), agar (15 g) were dissolved in distilled water with the final volume 1 l. The pH was adjusted to 7.0 with NaOH. After autoclaving and cooling down to 55
• C, 100 mg of ampicillin (final concentration 100 µg ml −1 ) was added with 1 ml of IPTG (100 mM) and 2 ml of X-gal (20 mg ml −1 in dimethylfomamide) per litre.
Transformation procedure on the chip
The competent cells were loaded on the chip through the 'cell in' port by opening valves 4 and 5. Once the cell solution flowed through the whole channel, valve 5 was closed. The chamber was dead-end-filled by pushing the air into the gas-permeable chip, then valve 4 was closed. After the chambers were filled with cells, valve 1 was opened, then, plasmid DNA was loaded through the 'DNA in' port to push the reagents into the mixing rings. Then the two solutions were mixed by operating valves 7, 8, and 9 sequentially for mixing. The chip was kept at 0 • C during the loading and the mixing procedure, then the temperature was increased to 42
• C for 30 s, and decreased to 0
• C for 2 min to allow the transformation of the plasmid DNA into the competent cells. Finally, valves 1, 3, and 6 were opened, and the transformation products were collected at the 'output' ports. 
Results and discussion
The basic linear process for the ligation that was implemented consists of loading and metering target DNA, vector and enzyme, mixing together and recovery of the ligated samples from the chip. The incubation step for the ligation was carried out on a thermal stage or a heat block. The procedure for a single instance of these operations is illustrated in figure 1(C) . The batch processing took place in a linear fashion; valves and cross-junctions were used to load different segments of a channel with three reagents: target DNA, linear vector, and enzyme. Because of the low Reynolds number, diffusion-controlled mixing in such a channel is impractically slow [2, 18] . Therefore, the entire 6 nl reaction volume was loaded into a rotary mixer, i.e. a ring with a peristaltic pump, allowing rapid mixing [12] . The ligation mixture was incubated on a thermal controller at 37
• C for 15 min followed by room temperature incubation further •: E.coli bacterial cell; : polystyrene microbead. E. coli cells containing enhanced green fluorescent protein (EGFP) were prepared and loaded onto the rotary pump. Cells captured under the microvalve regions after 30 s of the microvalve operation were counted and the damage rate was calculated compared to the total numbers of the cells loaded into the rotary mixer rings. Damaged cells exhibited distorted structures, reduced fluorescence and no discernable vital motion. Fluorescent microbeads, 2.3 µm, were used for as the control experiments. The percentage of the actually damaged cells on the microchip during the transformation process would be higher than this evaluation data because the competent cells are more fragile than the normal bacterial cells.
(This figure is in colour only in the electronic version) 15 min. To verify the ligation of the target DNA, we recovered the ligated products from the chip and plated them on agar medium with the blue-white screening method.
We ligated target DNA on more than six different chips (table 1) . Each chip was capable of parallel processing with the same number of valve operations as for a single process (figure 1). The highest yield was 2.4 × 10 5 of colony forming unit (CFU)/µg of DNA with 17.4% of the highest ligation efficiency showing 11.1 ± 3.8% of average efficiency compared to the conventional tube method. A further six chips were used as negative controls in which water was loaded instead of the target DNA; no white colony was present in any of these cases. These results show that it is possible to accomplish enzymatic ligation for molecular biology with nanolitres of the target DNA and vectors on a chip and thereby reduce the sample amounts of the ligation process by three orders of magnitude over conventional methods.
This parallel scheme allows each processor to be customized. We designed three processors on a chip for gene transformation to meter different volumes of samples, to facilitate the evaluation of the optimal conditions of the process (figure 2). The volumes of cell solution used in the top, middle and bottom processors were 1.25, 1.50 and 1.75 nl, respectively. The total volumes of each rotary reactor were 2.5, 3.0, and 3.5 nl, so 1.25, 1.50 and 1.75 nl of plasmid DNA or vector were added to the cell volumes, respectively.
We successfully transformed plasmid DNA to chemically treated competent cells on nine different chips ( figure 2 and table 2 ). For six of these chips we confirmed increased ligation efficiency from 8.9±0.5% to 12.9±2.9% and 19.8±3.4% with 2.5, 3, and 3.5 nl of 1:1 mixture of plasmid DNA and competent cells. We interpret the increased transformation efficiency with the increased total volume of the reaction as possibly due to damage to competent cells during the active mixing process or to thermal fluctuations when loading material onto the chip. Figure 3 shows the evaluation of the viability of cells during the mechanical pumping process. The number of bacterial cells captured under the valve region in the microfluidic channel was reduced from about 40% to 20% with increased pumping speed of the fluid from 61 µm s −1
(1 Hz of the sequential operation of the three microvalves for a rotary mixer) to 149 µm s −1 (5 Hz). We therefore assume that 20%-30% of the cells could be damaged during the pumping process. We improved the on chip transformation efficiency with a slightly modified chip design (table 3; the chip picture is not shown). This chip has decreased the DNA to cell ratio from 40:1 to 25:1, with 6.0 × 10 5 DNA molecules and 2.4 × 10 4 competent cells. In conclusion, we have shown that it is possible to conduct fundamental molecular biology steps on an operated microfluidic chip with mechanically operated valve systems. Restriction of plasmids and ligation of them on a microfluidic chip were carried out with nanolitre volumes. Moreover, it has been demonstrated that introducing competent cells and conducting transformation with the heat shock method in nanolitre volume is available in microfluidic systems. These chips represent general processors for a molecular biology laboratory. There are several potential uses for a miniaturized microfluidic system for DNA ligation and gene transformation in more complicated biotechnology problems such as genomic DNA or cDNA libraries on a chip, and biophysical studies with limited target molecules.
